Dyasonic is here!
A Tubeless Triumph
Omnipod and Marvel joined forces to create a custom Marvel comic to celebrate representation for the diabetes community and empower people with diabetes to unleash their inner hero. Boom! Bam! Wham! You won't want to miss this original comic penned by a writer with diabetes.
Meet Omnya
Omnya is an ordinary high school student who loves science and technology and struggles to manage her type 1 diabetes. And, when she least expects it, D'Spayre creeps into every aspect of her life. With an Omnipod 5 on her arm, Omnya learns that when her glucose levels are in range, she can take on anything or anyone. Read about Omnya's epic transformation into Dyasonic in Dyasonic: Sound of Strength.
Share to Benefit People with Diabetes
For every Instagram post that includes a Dyasonic GIPHY or Sticker, Omnipod will donate $1 to Children with Diabetes, up to $25,000, to help families attend future Friends for Life Orlando conferences. Don't forget to tag Children with Diabetes and Omnipod to make your post count!
How to Use Dyasonic GIFs and Stickers:
Open the GIPHY app or go to Instagram Stories or Reels, then search "Omnipod" to find Dyasonic GIFs and stickers.
On Instagram, open your Story or Reel, tap the sticker icon, then choose GIF and search "Omnipod" to add it directly.
Use two fingers to resize and position the sticker anywhere on your Story or Reel.
Tag @Omnipod and @CWDiabetes, then share your Story or Reel to spread the fun!
The Friends for Life Orlando scholarship program helps make the conference an unforgettable experience for families managing type 1 diabetes and is designed for first-time attendees who might otherwise be unable to afford to attend. The scholarship covers registration for a family of four and provides a hotel stay at Disney's Coronado Springs Resort for the duration of the conference.
Children with Diabetes is a 501(c)3 dedicated to providing education and support to families living with type 1 diabetes.
Be sure to follow and tag us on Instagram!
@CWDiabetes | @Omnipod | @omnipoduk | @omnipodca | @omnipodau
Dyasonic: Sound of Strength.
A Must Read.
Can’t get your hands on a copy? Never fear, you can read it, share it and read it again with the Marvel E-Reader.
Pod Power
Discover your power with Omnipod 5. It's tubeless, waterproof*, and delivers insulin for up to 3 days (72 hours).
Let the journey begin...
Pod Experience Kit
The Pod Experience Kit* contains a real-size, real weight demo Pod*, without the insulin. It’s designed to give you an idea of what it feels like to wear a Pod, and get a sense of how discreet it can be.
*The Pod has an IP28 rating for up to 7.6 meters (25 feet) for 60 minutes. The Controller is not waterproof.
Risk Statement
The Omnipod 5 Automated Insulin Delivery System is a single hormone insulin delivery system intended to deliver U-100 insulin subcutaneously for the management of type 1 diabetes in persons aged 2 and older requiring insulin. The Omnipod 5 System is intended for single patient use. The Omnipod 5 System is indicated for use with NovoLog®/NovoRapid®, Humalog® / Liprolog®, Admelog® / Insulin lispro Sanofi®, Trurapi® / Insulin aspart Sanofi®, and Kirsty® U-100 insulin.
Refer to the Omnipod® 5 Automated Insulin Delivery System User Guide for complete safety information including indications, contraindications, warnings, cautions, and instructions.
WARNING: DO NOT start to use the Omnipod® 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycaemia or hyperglycaemia.
1. Brown S. et al. Diabetes Care (2021). Study in 240 people with T1D aged 6 - 70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose in adults/adolescents and children, standard therapy vs. 3-month Omnipod 5: 32.4% vs. 24.7%; 45.3% vs. 30.2%. Median time with low blood glucose in adults/adolescents and children, standard therapy vs. 3-mo Omnipod 5: 2.0% vs. 1.1%; 1.4% vs. 1.5%. Average A1c in adults/adolescents and children, standard therapy vs. Omnipod 5 = 7.16% vs 6.78%; 7.67% vs 6.99%. Average time (6AM-12AM) in Target Glucose range (from CGM) in adults/adolescents and children for standard therapy vs Omnipod 5 = 64.8% vs. 72.5%; 51.5% vs. 64.6%. Average time (12AM-6AM) in Target Glucose range (from CGM) in adults/adolescents and children for standard therapy vs Omnipod 5 = 64.3% vs. 78.1%; 55.3% vs. 78.1%. Study funded by Insulet.
2. Sherr JL, et al. Diabetes Care (2022). Study in 80 people with T1D aged 2 - 5.9 yrs involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose from CGM in standard therapy vs Omnipod 5 = 39.4% vs. 29.5%. Average time with low blood glucose from CGM in standard therapy vs Omnipod 5 = 3.41% vs. 2.13%. Average A1c in standard therapy vs. Omnipod 5 = 7.4% vs. 6.9%. Average time in Target Glucose range (6AM-12AM) from CGM in standard therapy vs Omnipod 5 = 56.9% vs. 63.7%. Average time in Target Glucose range (12AM-6AM) from CGM in standard therapy vs. Omnipod 5 = 58.2% vs 81.0%. Study funded by Insulet.
**It’s recommended to keep the Controller close by to respond to any alerts or alarms.
†Device components must be removed (and the Pod and CGM sensor should be disposed of) before X-ray, Magnetic Resonance Imaging (MRI), or Computed Tomography (CT) scan (or any similar test or procedure). In addition, the Controller and smartphone should be placed outside of the procedure room. Exposure to X- ray, MRI, or CT, treatment can damage these components. Check with your healthcare provider on Pod removal guidelines.
‡The Pod has an IP28 rating for up to 7.6 meters (25 feet) for 60 minutes. The Omnipod 5 Controller is not waterproof.
*The Pod Experience Kit is a non-functioning, needle free Pod, without the insulin. The Controller is not included.